Development of a target identification approach using native mass spectrometry
Abstract A key step in the development of new pharmaceutical drugs is the identification of the molecular target and distinguishing this from all other gene products that respond indirectly to the drug. Target identification remains a crucial process and a current bottleneck for advancing hits throu...
Enregistré dans:
Auteurs principaux: | Miaomiao Liu, Wesley C. Van Voorhis, Ronald J. Quinn |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/79735f1a181546f9a030b3da081e8bf6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
par: Michal Bassani-Sternberg, et autres
Publié: (2016) -
Stochastic palmitoylation of accessible cysteines in membrane proteins revealed by native mass spectrometry
par: Remco N. P. Rodenburg, et autres
Publié: (2017) -
Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals
par: Therese Wohlschlager, et autres
Publié: (2018) -
DATABASE OF LEPTOSPIRA PROTEIN SPECTRA FOR MASS-SPECTROMETRY IDENTIFICATION
par: N. V. Breneva, et autres
Publié: (2018) -
Reliable identification of protein-protein interactions by crosslinking mass spectrometry
par: Swantje Lenz, et autres
Publié: (2021)